These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12498734)

  • 1. Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms.
    Jiao HL; Zhao BL
    Toxicol Appl Pharmacol; 2002 Dec; 185(3):172-9. PubMed ID: 12498734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of green tea polyphenols on human HepG2 cells against oxidative damage of fenofibrate.
    Jiao HL; Ye P; Zhao BL
    Free Radic Biol Med; 2003 Nov; 35(9):1121-8. PubMed ID: 14572614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
    Melnick RL
    Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643.
    Vanden Heuvel JP; Kreder D; Belda B; Hannon DB; Nugent CA; Burns KA; Taylor MJ
    Toxicol Appl Pharmacol; 2003 May; 188(3):185-98. PubMed ID: 12729718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the peroxisome proliferator clofibric acid on superoxide dismutase expression in the human HepG2 hepatoma cell line.
    Bécuwe P; Bianchi A; Keller JM; Dauça M
    Biochem Pharmacol; 1999 Sep; 58(6):1025-33. PubMed ID: 10509755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peroxisome proliferator BR931 kills FaO cells by p53-dependent apoptosis.
    Simbula G; Pibiri M; Sanna L; Cossu C; Molotzu F; Columbano A; Ledda-Columbano GM
    Life Sci; 2004 Jun; 75(3):271-86. PubMed ID: 15135649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells.
    Yamashita M
    Eur J Pharmacol; 2007 Feb; 556(1-3):172-80. PubMed ID: 17113579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).
    Roberts RA; James NH; Woodyatt NJ; Macdonald N; Tugwood JD
    Carcinogenesis; 1998 Jan; 19(1):43-8. PubMed ID: 9472691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells.
    Shabalina IG; Panaretakis T; Bergstrand A; DePierre JW
    Carcinogenesis; 1999 Dec; 20(12):2237-46. PubMed ID: 10590214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
    Macdonald N; Holden PR; Roberts RA
    Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha.
    Gonzalez FJ; Peters JM; Cattley RC
    J Natl Cancer Inst; 1998 Nov; 90(22):1702-9. PubMed ID: 9827524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha.
    Gazouli M; Yao ZX; Boujrad N; Corton JC; Culty M; Papadopoulos V
    Endocrinology; 2002 Jul; 143(7):2571-83. PubMed ID: 12072389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
    Clavey V; Copin C; Mariotte MC; Baugé E; Chinetti G; Fruchart J; Fruchart JC; Dallongeville J; Staels B
    Cell Physiol Biochem; 1999; 9(3):139-49. PubMed ID: 10494028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators.
    Corton JC; Lapinskas PJ; Gonzalez FJ
    Mutat Res; 2000 Mar; 448(2):139-51. PubMed ID: 10725468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.
    Corton JC; Anderson SP; Stauber A
    Annu Rev Pharmacol Toxicol; 2000; 40():491-518. PubMed ID: 10836145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.
    Li Y; Glauert HP; Spear BT
    Biochem Pharmacol; 2000 Feb; 59(4):427-34. PubMed ID: 10644051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
    Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
    Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation.
    Liu H; Xiao Y; Xiong C; Wei A; Ruan J
    Eur J Pharmacol; 2011 Mar; 654(3):209-16. PubMed ID: 21241688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
    Liang F; Wang F; Zhang S; Gardner DG
    Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.